Journal of Gastroenterology

Papers
(The TQCC of Journal of Gastroenterology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Managing radiation safety and protection in gastroenterology in Japan: insights from the REX-GI study260
Ratio of submucosal thickness to total bowel wall thickness as a new sonographic parameter to estimate endoscopic remission of ulcerative colitis190
Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosis147
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom106
Correlation between mismatch repair and survival of patients with gastric cancer after 5-FU-based adjuvant chemotherapy87
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy80
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy68
Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease61
Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism55
Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus48
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers48
Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospectiv44
Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts44
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma42
Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varices41
STING and liver disease40
Successful induction of human chemically induced liver progenitors with small molecules from damaged liver38
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database35
Predictive factors for the progression of primary localized stage small-bowel follicular lymphoma34
Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data29
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial29
Associations between excessive supragastric belching and esophageal reflux factors in patients with PPI-refractory GERD in Japan28
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy28
Clinical practice guidelines for duodenal cancer 202127
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials27
The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery27
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis27
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis25
Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan25
Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan25
Current status and trends in ERCP and post-ERCP pancreatitis in Japan: a nationwide observational study24
Correction: Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis24
Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 202124
Acknowledgements24
Persistent body-weight change on achalasia and peroral endoscopic myotomy: a multicenter cohort study24
Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation23
A study for every second day administration of vonoprazan for maintenance treatment of erosive GERD (ESD von GERD): a multicenter randomized cross-over study23
Expert consensus on vaccination in patients with inflammatory bowel disease in Japan22
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey21
Is it necessary for endoscopic surveillance for achalasia patients?20
What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?20
Evaluation of cholecystectomy in older individuals using real-world data: a multilevel analysis based on a nationwide administrative database in Japan20
Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials20
Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma19
Targeting autophagy as a therapeutic strategy against pancreatic cancer19
Nationwide cohort study identifies clinical outcomes of angioectasia in patients with acute hematochezia19
Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study19
Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specime19
Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study18
Cancer pathways in serrated polyposis syndrome: is conventional more crucial than serrated?17
“Pathologist-independent” strategy for T1 colorectal cancer after endoscopic resection17
RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer17
Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases17
Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)17
Reply to “Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data”17
Gastric cancer and genomics: review of literature17
Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)17
Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-1917
Frequency of lymph node metastasis according to tumor location in clinical T1 early gastric cancer: supplementary analysis of the Japan Clinical Oncology Group study (JCOG0912)17
Reply to “promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy”16
Identification of novel plasma proteins as promising noninvasive biomarker for early diagnosis and surveillance of pancreatic ductal adenocarcinoma15
The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry15
Effect of blood product transfusion on the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma: a propensity score matching analysis15
Correction: Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multic15
Impact of ursodeoxycholic acid treatment on Fontan-associated liver disease15
Characteristics, outcomes, and risk factors of surgery for acute lower gastrointestinal bleeding: nationwide cohort study of 10,342 hematochezia cases15
Molecular imaging of gastrointestinal stromal tumor using anti-c-KIT antibody and its fragments14
Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy14
Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society14
Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance14
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation14
Physician–patient communication affects patient satisfaction in treatment decision-making: a structural equation modelling analysis of a web-based survey in patients with ulcerative colitis14
A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation13
Correction to: Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia13
Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation13
The role of stromal BMP/CXCL12 signaling axis in serrated polyp development13
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data13
Correction: Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer13
Renal manifestations in inflammatory bowel disease: a systematic review12
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study12
Treatment strategy after noncurative endoscopic resection for early gastric cancers in patients aged ≥ 85 years: a multicenter retrospective study in a highly aged area of Japan12
Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, rando12
Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY12
The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention12
Prevalence of colonoscopy in Japan using a large-scale health claims data compared to esophagogastroduodenoscopy12
Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis12
Acknowledgements11
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-co11
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer11
Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia11
Publisher Correction: Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study11
Correction: Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia11
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study11
Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy11
Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance11
Definitive-dose adjuvant radiotherapy following endoscopic submucosal dissection for superficial esophageal cancer11
HBeAg-positive patients with HBsAg  < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation11
Comprehensive aptamer-based screen of 1317 proteins uncovers improved stool protein markers of colorectal cancer10
Reply to: “COVID-19-associated liver injury (COVALI): role of hepatologists”10
Reply to “Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19”10
Activating KRAS and GNAS mutations in heterotopic submucosal glands of the stomach10
The antiferroptotic effect of indigo on ulcerative colitis10
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis10
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma10
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy10
Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection10
Response to letter to the editor regarding: “Alcohol-associated liver disease increases the risk of muscle reduction and mortality in patients with cirrhosis”10
Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia10
Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease10
Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis10
Multicenter prospective in vivo study of an endocytoscope system (ECS) for superficial esophageal cancer10
Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer10
Estimating cancer risk in immune-mediated inflammatory diseases exposed to varying doses of tumour necrosis factor inhibitors9
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer9
Acknowledgements9
Current status of type 1 (IgG4-related) autoimmune pancreatitis9
A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer9
Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway9
FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma9
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus9
A proposed risk assessment score for gastrointestinal stromal tumors based on evaluation of 19,030 cases from the National Cancer Database9
Letter to "The potential of an artificial intelligence for diagnosing MRI images in rectal cancer: multicenter collaborative trial"9
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study9
Growing evidence on the highly sensitive iTACT assay of hepatitis B core-related antigen for predicting hepatitis B virus reactivation9
0.05356502532959